<div id="content" class="col-md-12" style="">
<div data-drupal-messages-fallback="" class="hidden"/><div id="block-medsites-page-title" class="widget block">
<h1><span property="schema:name">Paraneoplastic Syndromes</span>
</h1>
</div>
<div id="block-medsites-content" class="widget block">
<article data-history-node-id="1033" role="article" about="/commodorecompendium/paraneoplastic-syndromes" typeof="schema:WebPage">
<div>
<div property="schema:text" class="field field--name-body field--type-text-with-summary field--label-hidden field__item"><div class="WordSection1">
<div style="border-bottom:solid windowtext 1.0pt; border-top:double windowtext 1.5pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Paraneoplastic Syndromes – Justin Lo</span></span></b></span></span></span></span></p>
</div>
<div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><a name="Paraneoplastic" id="Paraneoplastic"/><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Hypercalcemia of malignancy</span></span></b></span></span></span></span></p>
</div>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Background </span></span></span></span></span></span></p>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Caused</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> by PTHrP production, osteolytic lesions, and/or rarely exogenous Vit D</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">PTHrP </span></span></span><span style="font-size:12.0pt"><span style="font-family:Wingdings"><span style="color:black"></span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> Breast cancer, NSCLC (squamous)</span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Osteolysis </span></span></span><span style="font-size:12.0pt"><span style="font-family:Wingdings"><span style="color:black"></span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> Multiple Myeloma, Breast Cancer; </span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Exogenous Vit D </span></span></span><span style="font-size:12.0pt"><span style="font-family:Wingdings"><span style="color:black"></span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> Lymphoma</span></span></span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Evaluation</span></span></span></span></span></span></span></p>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Correct [Ca<sup>+2</sup>] for hypoalbuminemia: add 0.8 x (4.0 – albumin)</span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Send basic hyperCa<sup>+2</sup> work-up – PTH, Vit D, etc (see hypercalcemia section)</span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">PTHrP is called “Parathyroid Hormone-related Peptide-ARUP” in Epic</span></span></span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Management</span></span></span></span></span></span></p>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">First-line: IVF without calcium such as Normosol </span></span></span><span style="font-size:12.0pt"><span style="font-family:Wingdings"><span style="color:black"></span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black"> goal urinary output of 150-200 mL/hr</span></span></span></span></span></span></span>
<ul style="list-style-type:circle">
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Strict I/Os; Cautious IV fluids if pt w/cardiac or renal dysfunction</span></span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:9.0pt"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Add Furosemide if hypervolemic (do not empirically start)</span></span></span></span></span></span></span></span></li>
</ul>
</li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Second-line: Zoledronic acid 4mg IV (takes 24-48 hours to see effect)</span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">AMS or severe hypercalcemia (&gt;14mg/dL): calcitonin 4 IU/kg (req. attending approval) </span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Monitor creatinine, calcium and potassium </span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Begin treatment for underlying malignancy ASAP</span></span></span></span></span></span></span></li>
</ul>
<p> </p>
<p> </p>
<div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">SIADH</span></span></b></span></span></span></span></p>
</div>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Background</span></span></span></span></span></span></span></p>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Euvolemic hypotonic hyponatremia with urine sodium &gt;20 and typically urine Osm &gt;100</span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Associated with: SCLC (most common), head/neck cancers, breast cancer</span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">See "Nephrology" for additional information</span></span></span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Management</span></span></span></span></span></span></span></p>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Free water restriction to 800mL/day</span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Refractory: salt supplementation (e.g. salt tabs) +/- loop diuretic</span></span></span></span></span></span></span></li>
</ul>
</div>
<p> </p>
<p> </p>
<div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Carcinoid Syndrome</span></span></b></span></span></span></p>
</div>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Background</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Episodic</span></span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> flushing, diarrhea, wheezing/SOB due to secretion of histamine &amp; serotonin </span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Most common: Neuroendocrine tumors – GI (often with mets to liver and lung)</span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Evaluation</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Urine: UR 5-HIAA (ARUP)</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Imaging to identify tumor(s) (CT chest/abdomen/pelvis)</span></span></span></span></span></span></span></li>
</ul>
<p style="margin-left:25px"> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Management</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Short-term treatment: subQ or IV octreotide (see UpToDate for dosing)</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Antidiarrheals (Imodium, Lomotil, etc.) to slow transit</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Long-term treatment: depot (IM) forms of octreotide and lanreotide</span></span></span></span></span></span></span></li>
</ul>
<p> </p>
<p> </p>
<div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Autoimmune encephalitis, encephalomyelitis, and myelitis</span></span></b></span></span></span></p>
</div>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Background</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Encephalopathy (limbic or brainstem), +/- myelitis (limb ataxia, sensory deficits)</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Associated with small cell lung cancer and checkpoint inhibitor therapy</span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Evaluation</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">LP: make sure to order CSF oligoclonal bands &amp; CSF IgG index</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">“Paraneoplastic AutoAb Eval-MAYO” (add "CSF" to the front of the order name if for LP)</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">NMDA-R can be ordered as a standalone test  </span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">CT head </span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">EEG if concern for subclinical seizures</span></span></span></span></span></span></span></li>
</ul>
<p style="margin-left:25px"> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="tab-stops:.75in"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Management: </span></span><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Consult Neurology, for possible immunosuppressive therapy (steroids, IVIG)</span></span></span></span></span></span></span></span></p>
<p> </p>
<p> </p>
<div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Lambert-Eaton myasthenic syndrome (LEMS) </span></span></b></span></span></span></p>
</div>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Background</span></span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Muscle</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> weakness due to autoantibody against calcium channels resulting in </span></span><span style="font-size:12.0pt"><span style="font-family:&quot;Times New Roman&quot;,serif">↓</span></span> <span style="font-size:12.0pt"><span style="font-family:Palatino">ACh release</span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Associated</span></span><span style="font-size:12.0pt"><span style="font-family:Palatino"> with SCLC (most common) &amp; lymphoma</span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Presentation: Proximal muscle weakness, diminished DTRs </span></span></span></span></span></p>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Evaluation</span></span></span></span></span></p>
<ul>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Nerve conduction studies: EMG w/ NCV</span></span></span></span></span></span></span></li>
<li><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Serum “Paraneoplastic AutoAb Eval-MAYO”</span></span></span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Management: </span></span><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Consult Neurology</span></span></span></span></span></span></span></p>
</div>
</div>
</article>
</div>
</div>